Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2918 of 5804
-
Math model may Fine-Tune radiation for throat cancer patients
Knowledge-focused CompletedThis study is to determine whether a mathematical model can be used to choose a radiation delivery method to improve the rate of a rapid response.
Phase: NA • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Do some Addison's patients still make their own hormones? new study investigates.
Knowledge-focused OngoingIn autoimmune adrenal insufficiency, or Addison's disease (AD), the immune system attacks the adrenal cortex. As a result, the adrenal cells producing hormones such as cortisol and aldosterone are destroyed, leaving the body with insufficient levels to meet its needs. The common …
Phase: NA • Sponsor: University of Bergen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Nanochip could spot lymphoma relapse early
Knowledge-focused OngoingThis trial studies how well nanochip technology (immuno-tethered lipoplex nanoparticle \[ILN\] biochip) works in monitoring treatment response and in detecting relapse in participants with diffuse large B-cell lymphoma. Finding genetic markers for diffuse large B-cell lymphoma ma…
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Can a palliative care team boost quality of life for cancer surgery patients?
Symptom relief CompletedThe study goal is to compare surgeon-palliative care team co-management, versus surgeon alone management, of patients and family members preparing for major upper gastrointestinal cancer surgery. The study also aims to explore, using qualitative methods, the impact of surgeon-pal…
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Could your own fat cells tame rheumatoid arthritis?
Disease control CompletedHope Biosciences is conducting a research study of an investigational product called Hope Biosciences autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment for Rheumatoid Arthritis (RA). The study purpose is to evaluate the safety pr…
Phase: PHASE1, PHASE2 • Sponsor: Hope Biosciences LLC • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Experimental drug combo targets Hard-to-Treat cancers
Disease control CompletedThis phase I trial studies the side effects and best dose of PI3Kbeta inhibitor AZD8186 when given together with docetaxel in treating patients with solid tumors with PTEN or PIK3CB mutations that have spread to other places in the body (metastatic) or cannot be removed by surger…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Brain scans reveal how alcohol hijacks social emotions
Knowledge-focused CompletedBackground: Problem drinking affects nearly half the people who drink alcohol. Drinking alcohol affects a person's social behavior and brain structure, but researchers don't have a good understanding of how. They want to test a technique called neurofeedback to learn more about …
Phase: NA • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Heart shield: new trial aims to prevent chemo side effects in blood cancer patients
Symptom relief Recruiting nowThis phase II trial studies how well dexrazoxane hydrochloride works in preventing heart-related side effects of chemotherapy in participants with blood cancers, such as acute myeloid leukemia, myelodysplastic syndrome, chronic myeloid leukemia, and myeloproliferative neoplasms. …
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Simple blood test may spare heart patients unpleasant procedure
Diagnosis CompletedAtrial fibrillation is the most frequent heart rhythm disorder. Its symptomatic forms, resistant to drug therapy, require invasive management (catheter ablation), which exposes to potentially serious complications including thromboembolic complications. Despite anticoagulant trea…
Sponsor: Groupe Hospitalier de la Rochelle Ré Aunis • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
New hope for women with unexplained vulvar pain: team care vs. standard treatment
Symptom relief OngoingVulvodynia (i.e. chronic vulvar pain without identifiable cause) is a heterogeneous clinical entity with a complex multifactorial causation. It is long lasting and difficult to treat, and the general consensus of current guidelines states that patients with vulvodynia benefit fro…
Phase: NA • Sponsor: Norwegian University of Science and Technology • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Prebiotic fiber and exercise may ease inflammation in kidney patients
Disease control CompletedThe study is primarily designed to examine the effect of 16 weeks of prebiotic supplementation (resistant starch)and moderate intensity aerobic training on markers of inflammation in stage 3-4 patients with chronic kidney disease.
Phase: NA • Sponsor: Springfield College • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Exercise may alter breast tissue markers linked to cancer risk
Disease control OngoingThis research study is evaluating the effect of exercise on markers in breast tissue and blood of premenopausal women who have been found to have dense breast tissue on mammogram.
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug duo aims to tame High-Risk MDS
Disease control OngoingThis study will treat patients with previously untreated high grade myleodysplastic syndromes (MDS) with both omacetaxine mepesuccinate and azacitidine.
Phase: PHASE1, PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Pregnancy and opioids: new study aims to predict risks for mom and baby
Knowledge-focused Recruiting nowThe objective of this study is to better understand the comprehensive integration of both clinical and genetic factors that will help to identify mothers who could be at an increased risk of poor response to opioid substitution and infants at risk of significant neonatal abstinen…
Sponsor: Senthil Sadhasivam • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Can a 'female Viagra' help breast cancer survivors regain desire?
Symptom relief OngoingThe purpose of this study is to determine if it is feasible for women to take both Flibanserin and tamoxifen for the duration of the study. This study is also trying to find out if Flibanserin improves or has any effect on hyposexual desire disorder/HSDD in women who are taking t…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Eye scans may spot Alzheimer's early
Knowledge-focused Recruiting nowThe primary goals of this study are to use optical coherence tomography (OCT) angiography (blood vessel mapping) to: 1. Detect retinal blood vessel and blood flow changes in participants with dementia. 2. Detect amyloid protein deposits in the retinas of participants with dement…
Sponsor: Oregon Health and Science University • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:29 UTC
-
Shock to the system: brain stimulation may boost stroke rehab
Symptom relief CompletedStroke affects upwards of 800,000 Americans every year and has an enormous impact on the well-being of the American Veteran population with 6,000 new stroke admissions every year. Many of these stroke survivors are living with walking disabilities. Gait problems result in inabili…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 26, 2026 17:45 UTC
-
New sleep program aims to help both Alzheimer's patients and their caregivers rest better
Symptom relief CompletedStudies consistently show the negative health impact of sleep problems in both Alzheimer's disease (AD) patients and their caregivers. However, only a few sleep interventions have been conducted for AD patients or their caregivers in community settings and none have addressed bot…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Can extra support improve cancer trial experiences?
Symptom relief OngoingThis study will test whether adding personalized supportive care to medical treatment on a clinical trial affects the study participants' ability and desire to discuss their symptoms, their concerns about the future, and their approach to coping with cancer. The effects of suppor…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Experimental combo targets tough blood cancers
Disease control Recruiting nowThis is a phase I, open-label, dose-escalation study to determine the MTD of selumetinib when combined with the standard dose of azacitidine. Treatment will begin within 28 days of screening procedures. Treatment will continue indefinitely, provided that the patient continues to …
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC